Exchange: NYSE·Updated 07:58 PM EDT

VEEV News

News
all
press releases
Is Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?
According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Zacks
Is Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?
According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Zacks
More News
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks
Veeva to Host Virtual Investor Day on November 5, 2026
Veeva to Host Virtual Investor Day on November 5, 2026 Veeva to Host Virtual Investor Day on November 5, 2026PR NewswirePLEASANTON, Calif., Oct. 14, 2026PLEASANTON, Calif., Oct. 14, 2026 /PRNewswire/ -- Veeva Systems(NYSE: VEEV) will host its investor day virtually on Thursday, November 5, 2026...
PR Newswire
VEEV Expands IQVIA Partnership With Clinical Operations Software Suite
Veeva expands its IQVIA partnership with clinical operations software, boosting its market reach and growth prospects through wider adoption and integrated workflows.
Zacks
$1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today
Veeva Systems (NYSE:VEEV) has outperformed the market over the past 10 years by 9.08% on an annualized basis producing an average annual return of 22.87%. Currently, Veeva Systems has a market capitalization of $47.90read more...
Benzinga
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know
Veeva Systems (VEEV) reached $301.63 at the closing of the latest trading day, reflecting a +1.95% change compared to its last close.
Zacks
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms
VEEV's push into early-stage biotech could unlock long-term revenue opportunities as its streamlined software solutions simplify critical drug development processes.
Zacks
IQVIA Selects Veeva Clinical Operations Applications
IQVIA (NYSE:IQV) and Veeva Systems (NYSE: VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications that will be used across IQVIA clinical development studies. This extends the previously...
Business Wire
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
VEEV's strong second-quarter results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.
Zacks
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and QualityPR NewswirePLEASANTON, Calif., Oct. 8, 2026Eli Lilly and Company, Pfizer, Sanofi, UCB, and more share learnings speeding drug...
PR Newswire

Advertisement|Remove ads.